C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

The FDA placed semaglutide on their drug shortage list in 2023, meaning it is eligible for compounding. However, while compounded versions contain the same active ingredient as the original, they do ...

The world is facing two immediate health crises concerning drugs and vaccines: affordable and reliable access to life-sparing medicines and the safety and reliability of those medicines.

Prof Sir Stephen O'Rahilly, from the University of Cambridge, said the study needed to be interpreted "carefully" but provided "useful reassurance" about the drugs' safety in people with diabetes.

To ensure safety, patients are advised to verify that their pharmacy is licensed in their state and avoid buying weight-loss drugs online without a prescription. "Generally, compounded medications ...

A man was seriously injured after a drug lab exploded in a Whittier apartment Tuesday night, Jan. 14, police said. The 30-year-old was cited in the hospital for suspicion of converting, manufacturing, ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...

Keros Therapeutics on Wednesday announced that it will completely discontinue the Phase II TROPOS study of its investigational fusion protein cibotercept in pulmonary arterial hypertension after an ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...